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of both neutrophil aggregation and adhesion.3,4 After
myocardial ischemia and reperfusion, release of NO
from coronary endothelium decreases.5,6 Thus an NO
N itric oxide (NO) has cardioprotective effectsthrough several mechanisms, such as potent
vasodilator actions,1 antiplatelet activity,2 and inhibition
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donor given during the course of ischemia and reperfu-
sion might preserve coronary endothelial function and
decrease myocardial injury. However, in the presence
of superoxide, NO rapidly reacts with superoxide to
form peroxynitrite, which is a highly reactive species
that can induce lipid peroxidation and cause coronary
endothelial damage and myocardial injury.7 Therefore
NO during ischemia and reperfusion would have both
cardioprotective and harmful effects. Nitroglycerin
(NTG) is an organic NO donor and NTG supplementa-
tion in preservation solution has been reported to
enhance cardiac8,9 and pulmonary preservation.10
However, NTG might cause the formation of peroxyni-
trite and accelerate lipid peroxidation after reperfusion.
The purpose of this study was to describe the in vivo
efficacy of adding NTG in preservation solution. For
this purpose, coronary endothelial function, left ven-
tricular (LV) function, and metabolites of NO and
lipid peroxide levels were measured during the course
of ischemia and reperfusion with the use of the clini-
cally relevant canine model of orthotopic heart trans-
plantation.
Materials and methods
Donor preparation. Sixteen adult mongrel dogs were
divided randomly into 2 groups: the NTG-supplemented
group (group NTG, n = 8) and the control group (group C, n
= 8). All donor dogs were anesthetized with sodium pento-
barbital (30 mg/kg intravenously) followed by the intramus-
cular administration of atropine sulfate (0.04 mg/kg). The
dogs were intubated, their lungs mechanically ventilated, and
then placed in a supine position. Pancuronium bromide (0.1
mg/kg) was administered intravenously for muscle relax-
ation. A continuous infusion of sodium pentobarbital was
used to maintain anesthesia. An antibiotic, flomoxef (25
mg/kg intravenously), was administered to prevent infection.
Systemic blood pressure was continuously monitored.
After a median sternotomy, heparin sodium (500 U/kg
intravenously) was administered systemically, and the heart
and blood of the donor dog were removed as described
before.11,12 The heart was arrested by the infusion of cold
crystalloid cardioplegic solution (15 mL/kg: K+ 20 mmol/L,
Na+ 87 mmol/L, Ca++ 0.1 mmol/L, Cl– 97 mmol/L, HCO3– 10
mmol/L, glucose 25 gm/L).12 The heart was then flushed with
cold University of Wisconsin solution (15 mL/kg; ViaSpan,
Du Pont Pharmaceuticals, Wilmington, Del) infused at a con-
stant rate over a 2-minute period with a rotating pump (Mera
Blood Pump HCP-100, Senko Medical Instrument, Tokyo,
Japan). During the infusion of University of Wisconsin solu-
tion, aortic root pressure was measured. Eight donor hearts in
group NTG were flushed and preserved in University of
Wisconsin solution with NTG (0.1 mg/mL; Du Pont
Pharmaceuticals) supplementation, whereas 8 donor hearts in
group C, flushed and preserved in standard University of
Wisconsin solution, served as a control. The temperature of
solution was maintained at 4°C. The hearts were placed in a
plastic bag containing the cold University of Wisconsin solu-
tion and were preserved at 1°C for 24 hours.
Recipient preparation. After 24 hours, the hearts were
transplanted into 16 weight-matched recipient dogs by a stan-
dard technique of orthotopic heart transplantation. All recipi-
ent dogs were anesthetized and pretreated in the same man-
ner as the donor dogs and received methylprednisolone (500
mg intravenously) and indomethacin (50 mg by rectum) after
induction for the purpose of stabilizing the cardiopulmonary
bypass preparation.
All recipients were placed in a supine position. After a
median sternotomy and heparinization (500 U/kg intra-
venously), cardiopulmonary bypass with moderate hypother-
mia was instituted with a heart-lung machine consisting of a
centrifugal pump (Bio-Pump BP-80; Medtronic Bio-
Medicus, Eden Prairie, Minn) and a membrane oxygenator
(D705 Midiflo System; Dideco, Mirandola, Italy), which was
primed with blood from the donor dog. After the ascending
aorta had been crossclamped, the recipient heart was
removed, and the donor heart was transplanted. The donor
heart was topically cooled with iced slush and was flushed
twice with cold crystalloid cardioplegic solution (5 mL/kg)
during the procedure. After reperfusion, the heart was electri-
cally defibrillated, if necessary. Fifteen minutes after reperfu-
sion, calcium chloride was given to correct the serum calci-
um level, and 30 minutes after reperfusion, ventricular pacing
was instituted at a rate of 150 beats/min by the external pacer
(Chronocor VI, model 5012, Telectronics Pacing Systems,
Englewood, Colo).
The heart rate was maintained at 150 beats/min by pacing
the right ventricle during the assessment period. All signals
(electrocardiogram, pressures, flows, and volume) were
continuously monitored on a multichannel oscillograph
(Polygraph 360 system, NEC Sanei, Tokyo, Japan) and on-
line digitized at 200 Hz with an analog-to-digital converter
(MacLab System, ADInstruments, Ltd, Dunedin North, New
Zealand) and recorded on a digital computer (Macintosh
Quadra 700, Apple Computer, Inc, Cupertino, Calif). After
the measurements, all dogs were killed by means of an over-
dose of intravenous sodium pentobarbital and potassium
chloride. Each dog’s heart was removed from the chest, and
the right and left ventricles (the free wall and the septum)
were weighed. LV free wall specimens were taken for the
measurement of myocardial water content. 
Data analysis 
Coronary endothelial function. Up to 150 minutes after
reperfusion, coronary endothelial function was assessed dur-
ing cardiopulmonary bypass with the left ventricle vented. At
15, 30, 60, and 150 minutes after reperfusion, coronary vas-
cular resistance was measured without inotropic or vasodila-
tory agents. Coronary vascular resistance was calculated as
the mean aortic root pressure divided by the mean coronary
flow. During 70 to 150 minutes after reperfusion, endotheli-
um-dependent and -independent coronary relaxations were
induced by direct infusions of acetylcholine and sodium
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nitroprusside, respectively, as described previously.13 As
shown in Fig 1, A, the coronary vessels were isolated from
the systemic circuit by crossclamping the ascending aorta and
were perfused with oxygenated blood through a 14-gauge
cannula connected to the side arm of the arterial line. To drain
the entire coronary venous return for the flow measurement,
a cannula was placed in the right ventricle through the right
atrium, and the tapes around the superior and inferior venae
cavae and the main pulmonary artery were snared. Coronary
flow was measured by an in-line electromagnetic flow probe
connected with a flowmeter (model MFV-3200, Nihon
Kohden, Tokyo, Japan). The coronary pressure and flow were
allowed to self-regulate, and they were recorded at baseline
and during the infusion of 3, 10, 30, and 100 m g of acetyl-
choline for 60 seconds. Coronary pressure and flow were
then allowed to return to baseline, and they were recorded
after 1000 m g of sodium nitroprusside for 60 seconds. Percent
coronary relaxation was calculated as (baseline resistance –
minimal resistance)/baseline resistance · 100 (%).
Conventional hemodynamic variables. All recipients were
disconnected from cardiopulmonary bypass 150 minutes
after reperfusion without inotropic or vasodilatory agents,
and conventional hemodynamic variables (heart rate, left
atrial pressure, mean aortic pressure, and aortic flow) were
obtained. The left atrial pressure was maintained at 10 mm
Hg during the assessment period.
LV function. For 150 to 180 minutes after reperfusion, LV
function was assessed during right heart bypass without
inotropic or vasodilatory agents. A right heart bypass prepa-
ration was established as shown in Fig 1, B.11,12 The tapes
around the superior and inferior venae cavae were snared to
direct systemic venous blood return into a reservoir. An arte-
rial cannula was inserted into the main pulmonary artery, and
the blood oxygenated with a membrane oxygenator was
pumped back to the main pulmonary artery. The entire coro-
nary venous return was drained for the flow measurement
and the oximetry. To measure the LV volume, a 7F 12-
electrode conductance catheter (Sentron B.V., Roden, The
Netherlands) was inserted into the left ventricle through the
apex. The catheter was attached to a signal generator/proces-
sor (Sigma 5, Leycom, Oegstageest, The Netherlands).14 A
catheter-tip micromanometer (model MPC-500, Millar
Instruments, Inc, Houston, Tex) was inserted into the left ven-
tricle, and LV pressure–volume loops were then constructed.
A 14-mm ultrasonic flow probe connected with the flowme-
ter (model T208, Transonic Systems, Inc, New York, NY)
was positioned around the ascending aorta for the measure-
ment of aortic flow to calibrate the volume signal of the con-
ductance catheter. Right heart bypass was instituted to control
the LV venous return and to decompress the right ventricle
completely, thereby eliminating parallel conductance varia-
tion. The parallel conductance volume was calculated by
transiently altering blood conductivity by the injection of
hypertonic saline solution (5 mL of 10% NaCl).14
Multiple LV pressure–volume loops were obtained during
transient preload reduction by reducing bypass flow. The dig-
itized data were analyzed by computer algorithms using a C-
language–type program developed in our laboratory with an
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Fig 1. A, Cardiopulmonary bypass for the assessment of coronary endothelial function. The coronary vessels were
isolated from the systemic circuit by crossclamping the ascending aorta and were perfused with oxygenated blood
through the side arm of the arterial line. Acetylcholine and sodium nitroprusside were infused from this side arm
for the assessment of coronary endothelial function. ACh, Acetylcholine; SNP, sodium nitroprusside; RV, right
ventricular; LV, left ventricular. B, Right heart bypass for the assessment of left ventricular function. To measure
the left ventricular pressure–volume loop, a catheter-tip micromanometer and conductance catheter were insert-
ed into the left ventricle. Right heart bypass was instituted to control the left ventricular venous return and to com-
pletely decompress the right ventricle, thereby eliminating parallel conductance variation.
A B
Intel 486–based personal computer (Vision, IBM Japan,
Tokyo, Japan). LV contractility was evaluated by the end-sys-
tolic pressure–volume (P
es
–V
es
) relation,15 the stroke
work–end-diastolic volume (SW–V
ed) relation,16 and the
maximum rate of change of LV pressure–end-diastolic vol-
ume (dP/dt
max
–V
ed) relation.17 The Pes–Ves relation was fitted
by linear regression to obtain the slope (E
es
) and the volume
intercept (V0,es), and the volume associated with Pes of 100
mm Hg (V100,es) was calculated. SW calculated as the area
inside the pressure–volume loop was plotted against V
ed to
obtain the slope (MSW) and the volume intercept (V0,SW) of
the SW–V
ed relation. The end-diastolic point was defined as
the point of the upstroke of the first derivative of the LV pres-
sure (dP/dt). The position of the SW–V
ed relation in the oper-
ating range was calculated by determining V
ed associated
with SW of 500 mm Hg · mL (V500,SW). In the same way, the
slope (dE/dt
max
) and the volume intercept (V0,dP/dt) of the
dP/dt
max
–V
ed relation were obtained, and Ved associated with
a dP/dt
max
of 1000 mm Hg/sec (V1000,dP/dt) was calculated. In
addition, LV stiffness (b ) was determined by fitting end-dias-
tolic pressure-volume points to the exponential relation as
described previously.18
Myocardial energetics. During 150 to 180 minutes after
reperfusion, multiple steady-state pressure–volume loops,
coronary flow, and arteriovenous oxygen difference data were
obtained at various preload volumes for the assessment of
myocardial energetics. Myocardial energetics was assessed
by the analysis of the relation between LV myocardial oxygen
consumption and systolic pressure-volume area as described
by Suga.15
Creatine kinase MB isoenzyme, lipid peroxide, and metabo-
lites of NO. Serum creatine kinase-MB isoenzyme (CK-MB)
level, serum lipid peroxide level, and the total plasma con-
centrations of nitrite and nitrate were measured before reper-
fusion and at 15, 30, 60, and 150 minutes after reperfusion.
Blood samples were obtained from the coronary sinus. Serum
lipid peroxide level was measured by means of a methylene
blue derivative method.19 The total plasma concentrations of
nitrite and nitrate were measured by converting into NO with
Aspergillus nitrate reductase and hydrochloric acid.20 The
amount of produced NO was then measured by an NO ana-
lyzer (model 270B, Sievers Instruments, Inc, Boulder, Colo).
Myocardial water content. LV free wall specimens taken
after experiments were weighed just after collection (wet
weight) and after 24 hours’ desiccation (dry weight). The
myocardial water content was calculated by the formula:
Myocardial water content = (Wet weight – Dry weight)/
Wet weight · 100 (%).
Statistical analysis. Results are presented as mean ± stan-
dard deviation. The Student unpaired t test was used for the
variables determined once during the experiment to examine
the difference between the 2 groups. Two-factor analysis of
variance with repeated measures on 1 factor21 was used for
the variables measured in series. This analysis clarified
whether each of (1) repeated measures factor and (2) non-
repeated measures factor was significantly different among or
between the levels and also whether (3) interaction between
the 2 factors was significant. Our major interest in using this
analysis (2-factor analysis of variance with repeated mea-
sures on 1 factor) was to see whether the variables were sta-
tistically different between group NTG and group C.
Animal care. All animals received humane care in compli-
ance with the “Principles of Laboratory Animal Care” for-
mulated by the National Society for Medical Research and
the “Guide for the Care and Use of Laboratory Animals” pre-
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Fig 2. The changes of coronary vascular resistance at 15, 30,
60, and 150 minutes after reperfusion in group NTG and
group C. Two-factor analysis of variance with repeated mea-
sures on 1 factor showed that the changes of coronary vascu-
lar resistance were marginally different between the 2 groups
(P = .08). Data are presented as mean ± standard deviation. 
Fig 3. Percent endothelium-dependent coronary relaxation
induced by acetylcholine and percent endothelium-indepen-
dent coronary relaxation induced by sodium nitroprusside in
group NTG and group C. The 2 groups were similar with
respect to percent endothelium-dependent coronary relax-
ation induced by acetylcholine and percent endothelium-
independent coronary relaxation induced by sodium nitroprus-
side. ACh, Acetylcholine; SNP, sodium nitroprusside. Data are
presented as mean ± standard deviation.
pared by the Institute of Laboratory Animal Resources and
published by the National Institutes of Health (NIH
Publication No. 86-23, revised 1985). This experiment was
reviewed by the Committee of the Ethics on Animal
Experiment in the Faculty of Medicine, Kyushu University,
and carried out under the control of the Guidelines for
Animal Experimentation in the Faculty of Medicine, Kyushu
University and The Law (No. 105) and Notification (No. 6)
of the Government.
Results
All the dogs in both groups were successfully dis-
connected from cardiopulmonary bypass. In group C
all dogs required ventricular pacing, whereas in group
NTG, 5 of 8 dogs were weaned from cardiopulmonary
bypass in sinus rhythm. No significant difference was
observed between the 2 groups in regard to donor
weight (group NTG, 16.1 ± 1.7 kg; group C, 15.0 ± 1.5
kg; P = .19) and aortic root pressure during the infusion
of University of Wisconsin solution (group NTG, 42.3
± 5.9 mm Hg; group C, 44.4 ± 3.0 mm Hg; P = .4).
There was no difference in aortic flow measured at a
left atrial pressure of 7 mm Hg for the assessment of
cardiac function of pretransplant donor hearts (group
NTG, 1119 ± 196 mL/min; group C, 1102 ± 298
mL/min; P = .9). The 2 groups were similar with respect
to recipient weight (group NTG, 16.4 ± 1.4 kg; group C,
15.3 ± 1.4 kg; P = .16), total ischemic time (group NTG,
24.5 ± 0.8 hours; group C, 24.6 ± 0.8 hours; P = .98),
and implantation time (group NTG, 74.1 ± 7.8 minutes;
group C, 71.9 ± 10.8 minutes; P = .6).
Coronary endothelial function. The changes of
coronary vascular resistance 15, 30, 60, and 150 min-
utes after reperfusion are shown in Fig 2. Two-factor
analysis of variance with repeated measures on 1 factor
showed that the changes of coronary vascular resis-
tance were marginally different between the 2 groups
(P = .08), but neither coronary vascular resistance
against time nor the interaction term was significant (P
= .9, P = .10, respectively). These statistical analyses
indicate that coronary vascular resistance tended to be
lower in the NTG group than in the control group, but
the changes of coronary vascular resistance could not
be statistically proved to be dependent on elapsing time
after reperfusion. As shown in Fig 3, the 2 groups were
similar with respect to percent endothelium-dependent
coronary relaxation induced by acetylcholine and per-
cent endothelium-independent coronary relaxation
induced by sodium nitroprusside.
Conventional hemodynamic variables. Conven-
tional hemodynamic variables at 150 minutes after
reperfusion are provided in Table I. Mean aortic pres-
sure and aortic flow in group NTG were significantly
higher than those in group C.
LV function. Parameters of systolic ventricular func-
tion are provided in Table II. Indices of systolic ven-
tricular function, E
es
, MSW, and dE/dtmax, of group
NTG were all significantly higher than those of group
C. The differences of V0,es and V0,SW between the 2
groups were significant. All 3 relations in group NTG
were shifted significantly toward the left in the operat-
ing range compared with those of group C, manifested
by the differences in V100,es, V500,SW, and V1000,dP/dt. The
parameters of contractility of 10 normal adult mongrel
dogs measured during right heart bypass without
inotropic or vasodilatory agents are shown in Table II
to appreciate the degree of dysfunction after transplan-
tation. The 2 groups were similar with respect to para-
meter of diastolic ventricular function, the degree of
curvature that reflected end-diastolic chamber stiffness,
b (group NTG, 0.108 ± 0.040; group C, 0.108 ± 0.047;
P = .99). Chamber stiffness, b , of 10 normal adult mon-
grel dogs was 0.084 ± 0.025.
Myocardial energetics. The 2 groups were similar
with respect to the slope of the myocardial oxygen con-
sumption–systolic pressure-volume area relation
(group NTG, 1.69 ± 0.44 · 10–5; group C, 1.18 ± 0.76
· 10–5; P = .12), and the intercept (group NTG, 1.34 ±
0.50 · 10–2; group C, 1.36 ± 0.77 · 10–2; P = .95).
CK-MB isoenzyme, lipid peroxide, and metabo-
lites of NO. The changes of serum CK-MB level,
serum lipid peroxide level, and the total plasma con-
centrations of nitrite and nitrate before reperfusion and
15, 30, 60, and 150 minutes after reperfusion in group
NTG and group C are shown in Fig 4. No significant
difference was observed between the 2 groups in regard
to serum CK-MB level, serum lipid peroxide level, and
the total plasma concentrations of nitrite and nitrate
before reperfusion. Serum CK-MB levels in group
NTG tended to be higher than those in group C,
although the differences did not reach statistical signif-
icance. Two-factor analysis of variance with repeated
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Table I. Comparisons of the hemodynamics between
group NTG and group C after reperfusion
HR LAP mAOP AOF 
(beats/min) (mm Hg) (mm Hg) (mL/min)
Group NTG 150 ± 4 10.3 ± 0.8 91.0 ± 24.1 671 ± 150
Group C 151 ± 3 10.3 ± 0.9 68.1 ± 13.1 420 ± 172
P value .6 .9 .03 .008
Data are presented as mean ± standard deviation. Hemodynamics was mea-
sured without inotropic and vasodilatory agents. HR, Heart rate; LAP, left atri-
al pressure; mAOP, mean aortic pressure; AOF, aortic flow. 
measures on 1 factor showed that serum lipid peroxide
levels after reperfusion in group NTG were significant-
ly higher than those in group C (P = .02) and that the
total plasma concentrations of nitrite and nitrate after
reperfusion in group NTG were significantly higher
than those in group C (P = .001).
Myocardial water content. No significant differ-
ence in the myocardial water content was observed
between group NTG and group C: 76.6% ± 3.7% and
78.8% ± 1.1% (P = .12), respectively.
Discussion
Myocardial ischemia followed by reperfusion results
in coronary endothelial dysfunction and myocardial
injury. NO released by endothelial cells has many phys-
iologic functions and plays an important role in modu-
lating ischemia-reperfusion injury. Several studies have
shown NO to have cardioprotective effects,2,3,22,23 but
other data suggest that NO can exaggerate ischemia-
reperfusion injury by reacting with superoxide to form
peroxynitrite.7,24 Adding NTG, an organic NO donor,
to cardiac preservation solution would produce both
cardioprotective and deleterious effects. Pinsky and
colleagues,8 using a heterotopic rat transplantation
model, studied the effects of NO donors as additives to
cardiac preservation solution. They reported that the
addition of NTG to preservation solution enhanced
graft survival. Oz and associates9 reported the superi-
ority of NTG-containing preservation solution in rat
and baboon cardiac transplantation models. On the
other hand, some studies have reported the harmful
effects of NO. Finkel and colleagues25 reported the neg-
ative inotropic effects of NO in isolated hamster papil-
lary muscles. Matheis and associates,24 using a piglet
hypoxic model, showed that NO was involved in
myocardial reoxygenation injury. Brady and col-
leagues26 reported that NO reduced cardiac contractility
in guinea pig cardiac ventricular myocytes. The effects
of NO on cardiac tissue are still controversial, especial-
ly during the course of ischemia and reperfusion.
As we have hypothesized, NTG administration
caused an increase in serum lipid peroxide levels after
reperfusion, which indicated acceleration of lipid per-
oxidation. To the best of our knowledge, this is the first
study to demonstrate the elevation of serum lipid per-
oxide level by the administration of NTG in a clinical-
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Table II. Comparisons of the P
es
–V
es
, SW–V
ed, and dP/dtmax–Ved relations between group NTG and group C after
reperfusion
P
es
–V
es
relation
E
es
(mm Hg/mL) V0,es (mL) V100,es (mL)
Group NTG 9.3 ± 3.4 –2.4 ± 3.5 9.7 ± 2.9
Group C 6.1 ± 2.2 8.3 ± 11.1 26.5 ± 10.5
P value .04 .02 .0006
Normal* 9.1 ± 2.6 1.0 ± 5.2 13.4 ± 5.3
SW–V
ed relation
MSW (mm Hg) V0,SW (mL) V500,SW (mL)
Group NTG 58.3 ± 17.5 7.8 ± 3.7 17.0 ± 4.0
Group C 36.4 ± 10.0 19.2 ± 11.5 33.8 ± 11.8
P value .008 .02 .002
Normal* 88.7 ± 18.5 10.4 ± 5.1 16.3 ± 5.7
dP/dt
max
–V
ed relation
dE/dt
max
(mm Hg/[sec · mL]) V0,dP/dt (mL) V1000,dP/dt (mL)
Group NTG 79.4 ± 13.8 –3.0 ± 5.0 9.9 ± 3.5
Group C 54.9 ± 28.5 3.4 ± 20.3 26.1 ± 11.2
P value .04 .4 .002
Normal* 80.9 ± 10.8 –2.0 ± 4.6 11.9 ± 2.6
Pes, Left ventricular end-systolic pressure; Ves, end-systolic volume; Ees, slope of P
es
–V
es
relation; V0,es, volume axis intercept of P
es
–V
es
relation; V100,es, V
es
associated with P
es
of 100 mm Hg; SW, left ventricular stroke work; Ved, end-diastolic volume; MSW, slope of SW–V
ed relation; V0,SW, volume intercept of SW–Ved
relation; V500,SW, V
ed associated with stroke work of 500 mL · mm Hg; dP/dtmax, maximum rate of change of left ventricular pressure; dE/dtmax, slope of
dP/dt
max
–V
ed relation; V0,dP/dt, volume intercept of dP/dtmax–Ved relation; V1000,dP/dt, Ved associated with dP/dtmax of 1000 mm Hg/sec.
*Values of 10 normal adult mongrel dogs measured during right heart bypass without inotropic or vasodilatory agents. Data are presented as mean ± standard devia-
tion. Left ventricular systolic function was measured without inotropic and vasodilatory agents.
ly relevant canine model of orthotopic heart transplan-
tation. Although the difference did not reach statistical
significance, serum CK-MB levels after reperfusion of
NTG-treated dogs also tended to be higher. Since lipid
peroxidation is a free radical–induced chain reaction
involving polyunsaturated fatty acids in cell mem-
branes,27 these findings evidenced the harmful effect of
NO donated by NTG. These potentially deleterious
effects might be caused by peroxynitrite, which was
produced from NO in the presence of superoxide.7
No difference in coronary endothelial function was
detected between the 2 groups in this study. Our pilot
studies showed that percent coronary relaxations dur-
ing the infusion of both 100 m g of acetylcholine and
1000 m g of sodium nitroprusside in normal dogs were
more than 75%. Therefore coronary endothelial func-
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Fig 4. Serum CK-MB levels (A), serum lipid peroxide levels (B), and the total plasma concentrations of nitrite
and nitrate (C) before reperfusion and at 15, 30, 60, and 150 minutes after reperfusion in group NTG and group
C. Serum CK-MB levels in group NTG tended to be higher than those in group C, although the differences did
not reach statistical significance. Two-factor analysis of variance with repeated measures on 1 factor showed that
serum lipid peroxide levels after reperfusion in group NTG were significantly higher than those in group C (P =
.02) and that the total plasma concentrations of nitrite and nitrate after reperfusion in group NTG were signifi-
cantly higher than those in group C (P = .001). CK-MB, Creatine kinase-MB; LPO, lipid peroxide; NO2+NO3,
total plasma concentrations of nitrite and nitrate. Data are presented as mean ± standard deviation.
A
B
C
tion both of dogs receiving NTG and of those not
receiving NTG was similarly impaired. On the other
hand, conventional hemodynamic variables (mean aor-
tic pressure and aortic flow; Table I) of dogs treated
with NTG were superior to those of dogs without NTG
treatment. In addition, the load-independent parameters
of systolic ventricular function, E
es
, MSW, and dE/dtmax,
of dogs treated with NTG were superior to those of
dogs without NTG treatment (Table II). Although there
was no difference in LV end-diastolic chamber stiffness
between the 2 groups, LV pressure–volume loops of
dogs treated with NTG shifted significantly toward the
left compared with those of dogs without NTG treat-
ment. These results strongly indicated that contractility
of NTG-treated dogs was well preserved despite the
exaggeration of lipid peroxidation. Since we did not
administer any inotropic agents for the weaning from
cardiopulmonary bypass, and since the implanted
hearts were completely denervated, it may be safely
assumed that the improved ventricular function direct-
ly reflected preserved intrinsic contractility of hearts
treated with NTG. 
Several mechanisms of the cardioprotective effect of
NO have been postulated. One of the earliest observed
abnormalities in ischemia-reperfusion injury is an
endothelial dysfunction manifested by a loss of NO-
dependent vasodilation.5,6 Thus the administration of
an NO donor during the course of ischemia and reper-
fusion is a reasonable strategy for the treatment of
ischemia-reperfusion injury. The inhibition of neu-
trophil aggregation and adhesion by NO also could
play a greater role because the postischemic blood flow
defects, so-called “no-reflow” phenomenon, after
reperfusion is mediated by neutrophil embolization of
the resistance vessels.28 In addition, the antiplatelet
activity of NO also could contribute to the improve-
ment of ventricular function by preventing coronary
thrombosis. Besides the cardioprotective effect of NO,
NO might have a direct effect on myocytes to improve
cardiac contractile function. Kojda and colleagues29
reported that organic nitrates such as NTG stimulated
cyclic adenosine monophosphate–dependent protein
kinase, thereby improving contractile response of rat
ventricular myocytes. These cardioprotective effects
and the enhancement of contractility with NO might
have counteracted the NO-induced exaggeration of
lipid peroxidation, which resulted in superior ventricu-
lar function of the NTG-treated hearts. Our finding
implied that NTG has a cardioprotective effect, despite
evidence of increased lipid peroxidation. Our prelimi-
nary experiment using an isolated rabbit heart prepara-
tion showed similar paradoxic findings with L-arginine.
The result indicated that these paradoxic findings are
related to NO itself and not limited to NTG. Since L-
arginine is known to suppress neutrophil adhesion to
the endothelium, the mechanism of cardioprotective
effects of NTG may relate to inhibition of neutrophil
activation. Further study is warranted to investigate the
exact mechanism and interaction of the cardioprotec-
tive and free radical–producing effects of NO produced
from NTG, and NTG itself.
Our results showed higher levels of nitrite and nitrate
in the NTG-treated dogs after reperfusion. Persistently
higher level of nitrite and nitrate was probably due to
the longer half-life of nitrate (3.8 hours).21 NTG is an
organic NO donor; that is, the conversion from NTG to
NO requires enzymatic activity.30 It was very likely
that NTG was not converted to NO until the time of
reperfusion, because the enzymatic activity responsible
for NO production must have been suppressed during
the cold preservation period. This presumption was
partly supported by the finding that there was no dif-
ference in aortic root pressure during the infusion of
University of Wisconsin solution with or without NTG
at an infusion temperature of 4°C. The feature of the
enzyme-dependent NO production may be the advan-
tage of NTG over spontaneous NO donors, such as
sodium nitroprusside.30 Spontaneous NO donors may
release NO during the cold preservation period. Since
the half-life of NO is extremely short, no NO would be
available at the time of reperfusion if spontaneous NO
donors were used as additives to preservation solution.
NTG contained in University of Wisconsin solution
may accumulate in coronary vessel walls and cardiac
myocytes during preservation. Accumulated NTG may
enzymatically convert to NO immediately after reper-
fusion. High-dose NO immediately after reperfusion
would have a cardioprotective effect. We therefore
assume that organic NO donors should be used as sup-
plements to preservation solution. The concentration of
NTG in the University of Wisconsin solution used in
our study was extremely high, which would cause
severe hypotension when given systemically or in ter-
minal warm blood cardioplegic solution. Thus adding
NTG in preservation solution was the only way to give
high-dose NTG.
In clinical practice, University of Wisconsin solution
has been introduced for heart preservation and has been
used widely. The ischemic time, however, is still limit-
ed to 6 to 8 hours with University of Wisconsin solu-
tion. Judging from our result in a clinically relevant
experimental model, we may be able to extend preser-
vation time by adding NTG to University of Wisconsin
solution. Before the clinical application, however, fur-
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ther study is warranted to investigate the exact mecha-
nism of the cardioprotective effect of NTG and to
develop a method to prevent the deleterious effect of
NTG.
The limitation of our experimental model was that
the assessment period was limited to 180 minutes after
reperfusion, because we were obliged to use right heart
bypass with a membrane oxygenator for functional
measurement. To examine the long-term effect of
NTG, we measured conventional hemodynamic para-
meters without using right heart bypass. In this prelim-
inary study, the hearts of 3 dogs preserved with
University of Wisconsin solution containing NTG were
able to maintain adequate cardiac output up to 8 hours
after reperfusion. At the left atrial pressure of 10 mm
Hg, cardiac output was 531 ± 196 mL/min without
inotropic agents and 1035 ± 468 mL/min with dobuta-
mine infusion at a rate of 5 µg · kg–1 · min–1. The car-
diac preservation period of 24 hours was selected
because our preliminary reports showed no difference
between the 2 groups after 6 or 12 hours of preserva-
tion in University of Wisconsin solution. Right ventric-
ular pacing was performed in all animals to fix the
heart rate at 150 beats/min during the assessment peri-
od because of the parameters of contractility affected
by the heart rate. Although the 2 groups were similar
with respect to end-diastolic chamber stiffness, right
ventricular pacing would influence the measurement of
end-diastolic pressure–volume relations.
In conclusion, NTG may have detrimental effects
evidenced by the increase in lipid peroxidation.
However, the overall effect of NTG was cardioprotec-
tive. Although the exact mechanism is yet to be clari-
fied, the superb cardioprotective effect of NTG over-
whelms the exaggeration of lipid peroxidation.
This study was prepared in consultation with Yasuhiko
Harasawa, MD, who assisted in the statistical analyses.
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